510(k) · Cleared
ClearedSAM IO Intraosseous Access System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Sam® Medical Products, Inc. · FMI Needle, Hypodermic, Single Lumen
Cleared on Nov 21, 2019 as substantially equivalent to K141117 (Vidacare, LLC, 2014) after a 170-day review. Its family tree reaches back 1 generation to 2014. 1 later device descends from it.
- Decided
- Nov 21, 2019
- Review
- 170 days
- Class
- Class II
- Product code
- FMI
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K141117 (2014). 1 later device descends from it, 1 citing it directly.
- Root · 1 generation backK141117 EZ-IO Intraosseous Infusion SystemVidacare, LLC · 2014 · Recalled
- This deviceK191488 SAM IO Intraosseous Access SystemSam® Medical Products, Inc. · 2019
- Descendant · cites it directly · 0 of its ownK240915 ZIEN IO Intraosseous Access SystemZien Medical Technologies, Inc. · 2024
Most influential descendants
Showing 1 of 1 · See all- K240915ZIEN IO Intraosseous Access SystemZien Medical Technologies, Inc. · 2024 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K141117 | EZ-IO Intraosseous Infusion System | Vidacare, LLC | 2014 | 3 |
| 0 (this device) | K191488 | SAM IO Intraosseous Access System | Sam® Medical Products, Inc. | 2019 | — |
| +1 | K240915 | ZIEN IO Intraosseous Access System | Zien Medical Technologies, Inc. | 2024 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2024 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FMI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FMI device
- #1 K252886 Pen Needlescore 14.5 · 4 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K141117 | EZ-IO Intraosseous Infusion SystemSummary page 4…Predicate Device: EZ-IO® lntraosseous Infusion System, Vidacare Corporation (now owned by Teleflex, Inc. (K141117) DEVICE DESCRIPTION: The SAM IO™ Intraosseous Access System consists of a single use disposable intraosseous (IO) needle assemb… | 2014 |
| † | K980196 | MD Tech Biopsy Set for Bone and Bone Marrow | 1998 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K240915 | ZIEN IO Intraosseous Access System | 2024 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All FMI devicesFMI Needle, Hypodermic, Single Lumen: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.
FDA decisions per year · FMI
11in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FMI
141in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FMI
1in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · FMI
2,424in 2025
MAUDE reports naming product code FMI, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 15 | 71 | 2 | 208 |
| 2008 | 10 | 85 | 4 | 177 |
| 2009 | 7 | 177 | 3 | 263 |
| 2010 | 15 | 119 | 79 | 249 |
| 2011 | 12 | 113 | 5 | 240 |
| 2012 | 17 | 107 | 1 | 215 |
| 2013 | 11 | 87 | 1 | 255 |
| 2014 | 14 | 155 | 3 | 287 |
| 2015 | 10 | 89 | 1 | 567 |
| 2016 | 20 | 217 | 0 | 941 |
| 2017 | 9 | 253 | 16 | 1,547 |
| 2018 | 20 | 176 | 0 | 2,398 |
| 2019 | 12 | 186 | 5 | 4,896 |
| 2020 | 11 | 263 | 3 | 4,245 |
| 2021 | 18 | 143 | 7 | 4,532 |
| 2022 | 23 | 189 | 0 | 4,885 |
| 2023 | 18 | 112 | 2 | 4,986 |
| 2024 | 3 | 90 | 1 | 4,053 |
| 2025 | 11 | 141 | 0 | 2,424 |
| 2026 | 12 | 119 | 1 (1) | — |
What is it indicated for?
The SAM IO™ Intraosseous Access System provides Intraosseous access in the proximal tibia, distal tibia and humeral
head (proximal humerus) of adults and pediatric patients, and the distal femur in pediatric patients when intravenous
access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases for up to 24 hours.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K191488 · printed Nov 6, 2026
Cite this page
510(k) Report. “K191488: SAM IO Intraosseous Access System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K191488
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026